Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Feb 20 2020

Evening Resident Seminar: PGY2 Transplant Resident Seminar–02.20.2020

February 20, 2020

5:30 PM - 7:30 PM

Location

UIC College of Pharmacy--Chicago 134-1

Address

833 South Wood St., IL 60612

Cost

Free

Please join us for our next evening Pharmacy Resident Seminar Presentation on Thursday, February 20, 2020, on the Chicago campus, Room 134-1  presented by Benito Valdepeñas , PharmD, RN and Anesia Reticker, PharmD. Registration is required in order to receive dinner.  Registration now closed.

Type of Activity: An Knowledge-Based Activity                                                                                                                             Target Audience: Pharmacists

Location and Time: Thursday, February 20, 2020,  5:30 pm - 7:30 pm

  • Live Presentation: UIC College of Pharmacy Chicago - Room 134-1

Agenda: 

5:30 pm - 6:00 pm     Welcome and Dinner (boxed dinners will be provided)

6:00 pm - 6:45 pm      Breaking Bad Immunoglobulins in Highly Sensitized Candidates for Kidney Transplantation
                                               Benito T. Valdepeñas III, PharmD, RN (PGY-2 Solid Transplant Pharmacy Practice Resident) 

6:45 pm - 7:30 pm      I Still Haven’t Found what I’m looking for: Clinical Trial Endpoints in the Treatment of Antibody Mediated Rejection
                                               Anesia Reticker, PharmD (PGY-2 Solid Transplant Pharmacy Practice Resident) 

Learning Objectives and CE information 

Presentation Title: I Still Haven’t Found what I’m looking for: Clinical Trial Endpoints in the Treatment of Antibody Mediated Rejection
ACPE UAN# 0016-0000-20-008-L01-P, 0.75 contact hours (0.075 CEUs)
Learning Objectives:
At the completion of this activity, the participant will be able to:

  • Describe the current treatment modalities and outcome measures in antibody mediated rejection in renal transplant recipients
  • Explain the limitations of current efficacy endpoints used in antibody mediated rejection clinical trials
  • Discuss future directions for the efficacy outcomes in the field of transplant

Presentation Title: Breaking Bad Immunoglobulins in Highly Sensitized Candidates for Kidney Transplantation
ACPE UAN#0016-0000-20-010-L01-P, 0.75 contact hours (0.075 CEUs)
Learning Objectives:
At the completion of this activity, the participant will be able to:

  • Discuss the current situation of organ transplantation and the need for desensitization in sensitized individuals
  • Discuss different desensitization strategies used to improve transplantation in highly sensitized candidates for kidney transplantation
  • Review safety and efficacy data on the use of IdeS as a desensitization strategy in kidney transplantation

 

Fees: There is no charge for attending this activity. Registration now closed. 

Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

Contact

April Quarles

Date posted

Nov 22, 2019

Date updated

Feb 13, 2020

Speakers

Statement of Continuing Pharmacy Education Credit: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Attendees have the opportunity to earn a total of 1.5 contact hours (0.15 CEUs) for the entire knowledge-based seminar. Attendance at the entire knowledge based activity, completion of the evaluation, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s). All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Prole ID and date of birth (MMDD) at the time of the activity. Please contact aquarl2@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Prole visit: www.MyCPEmonitor.net.